Article
07 May 2026
Virtual & Digital Health Digest
RANKINGS
This author falls within the Top 20% for their listed topics and industry categories. Based on Mondaq users readership, this author is ranked as VERY POPULAR in United States
AUTHORS CONTENT
Article
12 Mar 2026
FDA Issues Draft Guidance Clarifying Three-Year New Clinical Investigation Exclusivity
Article
26 Jan 2026
FDA "Cuts Red Tape" On Clinical Decision Support Software And Wearable Products For General Wellness
Article
20 Nov 2025
FDA's New "Plausible Mechanism Pathway" And Other Initiatives To Expedite Approval Of Drugs For Ultra-Rare Conditions
Article
12 Sep 2025
DTC Reforms And MAHA Proclamations: The MAHA Agenda And Its Focus On Prescription Drugs Continues To Take Shape
Article
08 Sep 2025
FDA Warning Letter To Fitness Wearable Sponsor Signals Increased Agency Focus On General Wellness Products
Article
29 Jul 2025
FDA Begins To Accept Nominations For The Commissioner's National Priority Voucher Pilot Program
Article
29 Jul 2025
Critical Medical Device Series: Part VI Navigating Innovation: The FDA's Role In Regulating Medical Technology (Video)
Article
25 Jul 2025
AI-llowed Or Infringing? Are AI Research Tools Protected Under The Safe Harbor?
Article
23 Jun 2025
FDA Announces Commissioner's National Priority Vouchers To Facilitate Expedited Access To Certain Drugs
Article
02 Jun 2025
AI, Medical Products & FDA, Part 1: AI Overview In Life Sciences (Podcast)
Article
16 Jan 2025
FDA Finalizes Its SIUU Guidance: An Analysis Of The Key Changes From The 2023 Draft Guidance
Article
03 Jan 2025
Virtual And Digital Health Digest
Article
17 Dec 2024
FDA Issues New Draft Guidance For Expedited Program For Serious Conditions — Accelerated Approval Of Drugs And Biologics
Article
28 Nov 2024
Virtual And Digital Health Digest
Article
29 Oct 2024
Virtual And Digital Health Digest
Article
27 Sep 2024
Virtual And Digital Health Digest
Article
30 Aug 2024
Virtual And Digital Health Digest
Article
29 Aug 2024
Virtual And Digital Health Digest (August 27, 2024)
Article
15 Jul 2024
FDA Issues Revised Draft Guidance On Addressing Misinformation About Medical Devices And Prescription Drugs
